Related Experiment Videos

Antinuclear antibody studies in juvenile chronic arthritis

Insights

Children with chronic arthritis and positive antinuclear antibodies (ANA) face the highest risk of iridocyclitis. Early onset and high ANA titres are key indicators for this serious complication in juvenile arthritis.

Area of Science:

  • Pediatric Rheumatology
  • Ophthalmology
  • Immunogenetics

Background:

  • Chronic arthritis in children, particularly juvenile idiopathic arthritis (JIA), can lead to serious complications like iridocyclitis.
  • Identifying risk factors for iridocyclitis is crucial for timely intervention and improved patient outcomes.

Purpose of the Study:

  • To identify predictors of chronic iridocyclitis in children diagnosed with chronic arthritis.
  • To investigate the correlation between antinuclear antibody (ANA) status, disease onset, and ocular involvement.

Main Methods:

  • Retrospective analysis of pediatric patients with chronic arthritis.
  • Assessment of demographic data, disease characteristics, antinuclear antibody (ANA) status and titres, and ocular manifestations.
  • Correlation of clinical findings with human leukocyte antigen (HLA) associations.

Main Results:

  • Young age of onset and positive antinuclear antibodies (ANA) were significant risk factors for chronic iridocyclitis.
  • ANA-negative children had a low risk of iridocyclitis, which occurred at an older age when present.
  • No iritis was observed in children developing juvenile chronic arthritis after age 9, irrespective of ANA status.
  • ANA titres correlated with erythrocyte sedimentation rate, active arthritis, and iridocyclitis.
  • Histocompatibility antigens A2 and DRw8 were associated with ANA-positive pauciarticular arthritis, while HLA-DR5 correlated with milder disease and HLA-B15/w62 with severe ocular involvement.

Conclusions:

  • Early-onset chronic arthritis with positive ANA strongly predicts iridocyclitis risk in children.
  • ANA titres and specific HLA types provide further insights into disease severity and ocular complications.
  • Risk stratification based on ANA status and age of onset can guide proactive ophthalmic surveillance in pediatric arthritis patients.

Related Concept Videos